- Home
- DHF vs ANIK Comparison
DHF vs ANIK Comparison
Compare DHF & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHF
- ANIK
- Stock Information
- Founded
- DHF 1998
- ANIK 1983
- Country
- DHF United States
- ANIK United States
- Employees
- DHF N/A
- ANIK N/A
- Industry
- DHF Finance Companies
- ANIK Medical/Dental Instruments
- Sector
- DHF Finance
- ANIK Health Care
- Exchange
- DHF Nasdaq
- ANIK Nasdaq
- Market Cap
- DHF 174.6M
- ANIK 196.6M
- IPO Year
- DHF N/A
- ANIK 1993
- Fundamental
- Price
- DHF $2.40
- ANIK $14.02
- Analyst Decision
- DHF
- ANIK Buy
- Analyst Count
- DHF 0
- ANIK 2
- Target Price
- DHF N/A
- ANIK $22.00
- AVG Volume (30 Days)
- DHF 451.1K
- ANIK 77.6K
- Earning Date
- DHF 01-01-0001
- ANIK 05-07-2025
- Dividend Yield
- DHF 7.65%
- ANIK N/A
- EPS Growth
- DHF N/A
- ANIK N/A
- EPS
- DHF N/A
- ANIK N/A
- Revenue
- DHF N/A
- ANIK $119,907,000.00
- Revenue This Year
- DHF N/A
- ANIK N/A
- Revenue Next Year
- DHF N/A
- ANIK $8.72
- P/E Ratio
- DHF N/A
- ANIK N/A
- Revenue Growth
- DHF N/A
- ANIK N/A
- 52 Week Low
- DHF $2.06
- ANIK $12.83
- 52 Week High
- DHF $2.39
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- DHF 42.17
- ANIK 41.05
- Support Level
- DHF $2.25
- ANIK $13.14
- Resistance Level
- DHF $2.43
- ANIK $14.32
- Average True Range (ATR)
- DHF 0.07
- ANIK 0.92
- MACD
- DHF 0.00
- ANIK 0.02
- Stochastic Oscillator
- DHF 54.55
- ANIK 45.42
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.